BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C
22 results:

  • 1. Fgf2 and ptpn11 play a role in cerebral injury caused by sevoflurane anesthesia.
    Zhang L; Xu L
    Medicine (Baltimore); 2023 Nov; 102(45):e36108. PubMed ID: 37960778
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic significance of shp2 (ptpn11) expression in solid tumors: A meta-analysis.
    Zhou J; Guo H; Zhang Y; Liu H; Dou Q
    PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PD-1 blockade delays tumor growth by inhibiting an intrinsic shp2/Ras/MAPK signalling in thyroid cancer cells.
    Liotti F; Kumar N; Prevete N; Marotta M; Sorriento D; Ieranò C; Ronchi A; Marino FZ; Moretti S; Colella R; Puxeddu E; Paladino S; Kano Y; Ohh M; Scala S; Melillo RM
    J Exp Clin Cancer Res; 2021 Jan; 40(1):22. PubMed ID: 33413561
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis.
    Oba T; Chino T; Soma A; Shimizu T; Ono M; Ito T; Kanai T; Maeno K; Ito KI
    Endocr J; 2020 Dec; 67(12):1215-1226. PubMed ID: 32814730
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ptpn11 Knockdown Prevents Changes in the Expression of Genes Controlling Cell Cycle, Chemotherapy Resistance, and Oncogene-Induced Senescence in Human thyroid Cells Overexpressing BRAF V600E Oncogenic Protein.
    Putlyaeva LV; Demin DE; Uvarova AN; Zinevich LS; Prokofjeva MM; Gazizova GR; Shagimardanova EI; Schwartz AM
    Biochemistry (Mosc); 2020 Jan; 85(1):108-118. PubMed ID: 32079522
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. thyroid cancer MR molecular imaging via shp2-targeted nanoparticles.
    Hu Z; Qin J; Li T; Guo J
    Int J Nanomedicine; 2019; 14():7365-7373. PubMed ID: 31686812
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of shp2 and Hook1 expression in patients with thyroid carcinoma.
    Cao J; Huang YQ; Jiao-Sun ; Lan XB; Ge MH
    Hum Pathol; 2018 Nov; 81():105-112. PubMed ID: 29953894
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. thyroid cancer Detection by Ultrasound Molecular Imaging with shp2-Targeted Perfluorocarbon Nanoparticles.
    Hu Z; Yang B; Li T; Li J
    Contrast Media Mol Imaging; 2018; 2018():8710862. PubMed ID: 29706844
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive Map and Functional Annotation of Human Pituitary and thyroid Proteome.
    Liu X; Guo Z; Sun H; Li W; Sun W
    J Proteome Res; 2017 Aug; 16(8):2680-2691. PubMed ID: 28678506
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recommendations for cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased cancer Risk.
    Villani A; Greer MC; Kalish JM; Nakagawara A; Nathanson KL; Pajtler KW; Pfister SM; Walsh MF; Wasserman JD; Zelley K; Kratz CP
    Clin Cancer Res; 2017 Jun; 23(12):e83-e90. PubMed ID: 28620009
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lipoic Acid Decreases the Viability of Breast cancer Cells and Activity of PTP1B and shp2.
    Kuban-Jankowska A; Gorska-Ponikowska M; Wozniak M
    Anticancer Res; 2017 Jun; 37(6):2893-2898. PubMed ID: 28551626
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.
    Ueshima C; Kataoka TR; Takei Y; Hirata M; Sugimoto A; Hirokawa M; Okayama Y; Blumberg RS; Haga H
    Cancer Med; 2017 Apr; 6(4):845-856. PubMed ID: 28332308
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis.
    Wang L; Zhang WP; Yao L; Zhang W; Zhu J; Zhang WC; Zhang YH; Wang Z; Yan QG; Guo Y; Fan LN; Liu YX; Huang GS
    Hum Pathol; 2015 Dec; 46(12):1913-21. PubMed ID: 26475096
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A rare case of Hodkin's lymphoma of the mediastinum imitating retrosternal goiter--retrospective analysis of the diagnostic process.
    Dedecjus M; Kędzierska A; Kozak J; Kordek R; Brzeziński J
    Pol Przegl Chir; 2012 Jul; 84(7):363-6. PubMed ID: 22935459
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study.
    Necchi V; Sommi P; Vanoli A; Manca R; Ricci V; Solcia E
    PLoS One; 2011; 6(6):e21317. PubMed ID: 21695063
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with cfc syndrome.
    Champion KJ; Bunag C; Estep AL; Jones JR; Bolt CH; Rogers RC; Rauen KA; Everman DB
    Clin Genet; 2011 May; 79(5):468-74. PubMed ID: 20735442
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
    Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
    Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Activating ptpn11 mutations play a minor role in pediatric and adult solid tumors.
    Martinelli S; Carta C; Flex E; Binni F; Cordisco EL; Moretti S; Puxeddu E; Tonacchera M; Pinchera A; McDowell HP; Dominici C; Rosolen A; Di Rocco C; Riccardi R; Celli P; Picardo M; Genuardi M; Grammatico P; Sorcini M; Tartaglia M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):124-9. PubMed ID: 16631468
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1.
    Hennige AM; Lammers R; Höppner W; Arlt D; Strack V; Teichmann R; Machicao F; Ullrich A; Häring HU; Kellerer M
    Endocrinology; 2001 Oct; 142(10):4441-7. PubMed ID: 11564708
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.